Showing 112 of 112on this page. Filters & sort apply to loaded results; URL updates for sharing.112 of 112 on this page
VIDEO: Genentech shares positive study data ahead of Susvimo relaunch
Genentech announces 5-Year data of susvimo for wet AMD from Portal study
Susvimo Approved for Wet Age-Related Macular Degeneration - MPR
New Data for Susvimo Demonstrates Sustained Efficacy in DME and DR ...
Genentech to Reintroduce Susvimo for Wet Age-related Macular ...
SUSVIMO (ocular implant - ranibizumab) - Macula Retina Vitreous Center
Susvimo (Ranibizumab Injection): Side Effects, Uses, Dosage ...
Susvimo Ocular Implants | Alternative to Eye Injections
FDA Expands Label for Genentech's Susvimo Implant to Include DR - Eyewire+
Genentech, Roche Recall Ophthalmology Biobetter Susvimo
FDA Approves Susvimo (ranibizumab) for the Treatment of Wet Age-Related ...
Susvimo for Neovascular (Wet) Age-Related Macular Degeneration ...
FDA expands label for Roche's eye disease implant Susvimo | pharmaphorum
Wet AMD and The New Susvimo Implant - Ophthalmology 360
New Drug Product: Susvimo - MPR
Genentech Provides 2-year, Phase 3 Data for Vabysmo and Susvimo - Eyewire+
VM - FDA Approves Genentech’s Susvimo for the Treatment of Diabetic ...
Phase III Data for Susvimo Show Promise in the Treatment of Two ...
Susvimo - FDA prescribing information, side effects and uses
New 2-Year Data for Genentech’s Vabysmo and Susvimo Show Potential of ...
New five-year data on Susvimo implant for nAMD - Insight
Susvimo (Genentech, Inc.): FDA Package Insert, Page 7
Susvimo (PDS with ranibizumab) is approved by FDA treatment for ...
Susvimo - Drug Information from Guideline Central
ASRS 2024: New data for Susvimo demonstrates sustained efficacy in DME, DR
FDA approves Susvimo for diabetic macular edema
Susvimo (ranibizumab) for Treating Wet Age‑related Macular Degeneration
FDA approves Susvimo for treatment of diabetic retinopathy
Genentech’s Susvimo receives new FDA indication for diabetic retinopathy
Genetech Susvimo (ranibizumab injection) Monograph - Guideline Central
Genentech Executive Discusses Vabysmo Pre-Filled Syringe and Susvimo ...
Susvimo: Uses, Taking, Side Effects, Warnings - Medicine.com
Susvimo: Package Insert / Prescribing Information
Genentech: Susvimo® (ranibizumab injection) - Information for ...
Favorable Long-Term Results With Ranibizumab Implant for Neovascular ...
SUSVIMO™ (ranibizumab injection) Durability Results
Susvimo: Pioneering Implant for Treating Wet Age-Related Macular ...
Susvimo因其眼部植入物组件更新再次在美国上市，用于治疗湿性AMD-上市-医保-临床适应症-香港济民药业
SUSVIMO® (ranibizumab injection) for nAMD, DME and DR
DailyMed - SUSVIMO- ranibizumab injection, solution
SUSVIMO® (ranibizumab injection) Surgical Procedure Videos
How SUSVIMO® Works | wAMD Treatment
Groundbreaking Eye Procedure for Treating Wet AMD
SUSVIMO™ (ranibizumab injection) a Treatment Option for nAMD
SUSVIMO® (ranibizumab injection) a Treatment Option for wet AMD and ...
ARCHWAY and PAGODA Trials for SUSVIMO® (ranibizumab injection)
ARCHWAY, PAGODA, and PAVILION Trials for SUSVIMO® (ranibizumab injection)
Visual Acuity Outcomes and DR severity of SUSVIMO® (ranibizumab injection)
Fewer Injections Preferred by AMD Patients—But at What Price?
FDA Approves Genentech’s Port Delivery System, Susvimo, a First-of-Its ...
Roche's two-year data on Susvimo® for eye diseases | Pharmaceutical ...
Portfolio - Three Aces
Forms and Documents | SUSVIMO® (ranibizumab injection)
SUSVIMO™ (ranibizumab injection) a Treatment Option for wet AMD
Patient Preference Data for SUSVIMO® (ranibizumab injection)
重磅！罗氏Susvimo获FDA批准，为糖尿病视网膜病变患者带来长效新疗法
How SUSVIMO® (ranibizumab injection) Works | An Anti-VEGF Treatment
Visual Acuity Outcomes of SUSVIMO™ (ranibizumab injection)
What is DR? | SUSVIMO® (ranibizumab injection)
SUSVIMO® (ranibizumab injection) Patient Resources
Healthcare Newsletter October 2021
Data Unveils Susvimo’s Enduring Power in Treating Diabetic Eye Diseases
Optician Online - CPD Archive
Helpful Resources for Your Practice | SUSVIMO® (ranibizumab injection)
Glance by Eyes On Eyecare | Read the Latest Eyecare Industry News
